Search

Mary Dosch Doubleday

from Snohomish, WA
Age ~70
Get Report
Also known as:
Mary D Doubleday, Mary M Doubleday, Mary W Doubleday
Phone and address:
7806 129Th Dr SE, Snohomish, WA 98290
(360) 863-2779
Related to:
Wendel William Doubleday, 64
Connected to:
Andrea J Doubleday, 73Bonita S Doubleday, 84Emma Doubleday, 33Kevin J Doubleday, 39Silvana G Doubleday, 65Thomas J Doubleday, 61Judith A Doublestein, 84Angel J Doubrava, 40Jaroslav Doubrava, 47Mary C Doubrava, 88

Mary Doubleday Phones & Addresses

  • 7806 129Th Dr SE, Snohomish, WA 98290 (360) 863-2779
  • Vail, AZ
  • Everett, WA
  • 1410 Avenida La Posta, Encinitas, CA 92024 (760) 633-1577
  • Twin Lakes, WI
  • Doylestown, PA
  • San Diego, CA
  • Fox Lake, IL
  • 7806 129Th Dr SE, Snohomish, WA 98290 (215) 794-1186

Work

Company: Naturize biosciences 2003 to 2005 Position: Office administrator

Education

Degree: High school graduate or higher

Resumes

Resumes

Mary Doubleday Photo 1

Mary Doubleday

View page
Work:
Naturize Biosciences 2003 - 2005
Office Administrator
Us Army Feild Staton Berlin 1983 - 1986
Signal Intelligence Enciphered Comms Analyst

Publications

Us Patents

Compounds And Methods For Modulation Of Estrogen Receptors

View page
US Patent:
6372739, Apr 16, 2002
Filed:
Jul 2, 2001
Appl. No.:
09/897048
Inventors:
Bernd M. Stein - San Diego CA
David Wesley Anderson - Poway CA
Mary Doubleday - Doylestown PA
Graziella I. Shevlin - San Diego CA
Adam Kois - San Diego CA
Sak Khammungkhune - San Diego CA
Ravi Kumar Jalluri - San Diego CA
Shripad S. Bhagwat - San Diego CA
Jeffrey A. McKie - San Diego CA
Assignee:
Signal Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 315377
US Classification:
5142335, 544151, 546187, 546193, 546196, 5483114, 548525, 549289
Abstract:
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same: wherein R , R , R , n and p are as defined here. Methods are also disclosed for modulating ER in cells and/or tissues expressing the same, such as bone, breast, prostate, uterus, CNS or the cardiovascular system. Methods for treating estrogen-related conditions are also disclosed, including conditions such as is breast cancer, osteoporosis, endometriosis, cardiovascular disease, hypercholesterolemia, prostatic hypertrophy, prostatic carcinomas, obesity, hot flashes, skin effects, mood swings, memory loss, and adverse reproductive effects associated with exposure to environmental chemicals or natural hormonal imbalances.

Neuroprotective Agents And Methods Related Thereto

View page
US Patent:
6399606, Jun 4, 2002
Filed:
Nov 27, 2000
Appl. No.:
09/724351
Inventors:
Moorthy S. S. Palanki - Encinitas CA
Shripad S. Bhagwat - San Diego CA
Hiroshi Sato - Omiya, JP
Paul E. Erdman - San Diego CA
Mary Doubleday - Doylestown PA
Assignee:
Nippon Kayaku Co., Ltd. - Tokyo
International Classification:
A61K 315377
US Classification:
5142372, 51425218, 514275, 514318, 514332, 514340, 514341, 514354, 514355, 514336, 514338, 514343, 514314, 514339, 514342, 544124, 544129, 544297, 544360, 546314, 546315, 546262, 546285, 546193, 546172, 5462697, 5462847, 5462804, 5462774, 5462731, 5462764, 5462791, 5462727, 5462681
Abstract:
Neuroprotective agents are disclosed having the following structure: wherein R , R , R , R and R are as defined herein. Such compounds have utility in the treatment of conditions which benefit from administration of neuroprotective agents generally, including treatment of central and peripheral nervous condition as well as for promoting nerve cell differentiation. Methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more of the compounds of this invention.

Compounds And Methods For Modulation Of Estrogen Receptors

View page
US Patent:
62914561, Sep 18, 2001
Filed:
Jan 27, 2000
Appl. No.:
9/492939
Inventors:
Bernd M. Stein - San Diego CA
David Wesley Anderson - Poway CA
May S. Sutherland - Bothell WA
Mary Doubleday - Doylestown PA
Graziella I. Shevlin - San Diego CA
Adam Kois - San Diego CA
Sak Khammungkhune - San Diego CA
Ravi Kumar Jalluri - San Diego CA
Shripad S. Bhagwat - San Diego CA
Jeffrey A. McKie - San Diego CA
Assignee:
Signal Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 315377
A61P 1908
C07D41312
US Classification:
5142335
Abstract:
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same: ##STR1## wherein R. sub. 1, R. sub. 2, R. sub. 3, n and p are as defined here. Methods are also disclosed for modulating ER in cells and/or tissues expressing the same, such as bone, breast, prostate, uterus, CNS or the cardiovascular system. Methods for treating estrogen-related conditions are also disclosed, including conditions such as is breast cancer, osteoporosis, endometriosis, cardiovascular disease, hypercholesterolemia, prostatic hypertrophy, prostatic carcinomas, obesity, hot flashes, skin effects, mood swings, memory loss, and adverse reproductive effects associated with exposure to environmental chemicals or natural hormonal imbalances.
Control profile
Mary Dosch Doubleday from Snohomish, WA, age ~70 Get Report